{
  "ticker": "LLY",
  "target_date": "2025-10-01",
  "actual_date": "2025-10-01",
  "collected_at": "2025-12-08T12:21:06.188897",
  "price": {
    "open": 762.18,
    "high": 832.08,
    "low": 762.18,
    "close": 824.2095336914062,
    "volume": 10124500,
    "change_1d_pct": 8.18,
    "change_7d_pct": 9.33,
    "change_30d_pct": 17.38
  },
  "technicals": {
    "rsi_14": 67.54,
    "sma_20": 749.47,
    "sma_50": 733.62,
    "macd": 8.589,
    "macd_signal": 4.767,
    "macd_histogram": 3.822,
    "bb_upper": 794.56,
    "bb_lower": 704.38,
    "price_vs_sma20_pct": 9.97,
    "price_vs_sma50_pct": 12.35,
    "volume_ratio": 2.6
  },
  "fundamentals": {
    "market_cap": 892507848704,
    "pe_ratio": 48.779762,
    "forward_pe": 43.93623,
    "price_to_book": 37.484753,
    "price_to_sales": 15.020378,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.47,
    "pct_from_52w_low": 59.61
  },
  "macro": {
    "spy": {
      "price": 668.45,
      "change_1d_pct": 0.34,
      "change_7d_pct": 0.79
    },
    "vix": {
      "level": 16.29,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.11
    },
    "dollar_index": {
      "level": 97.71
    },
    "gold": {
      "price": 3867.5
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Morgan Stanley Downgrades Novo Nordisk A/S (NVO) from Equal-Weight to Underweight",
      "source": "Yahoo",
      "datetime": 1759358790,
      "summary": "With significant revenue and dividend growth, Novo Nordisk A/S (NYSE:NVO) makes our list of the 20 Best Stocks to Buy and Hold for a Lifetime. Morgan Stanley downgraded Novo Nordisk A/S (NYSE:NVO) from Equal-Weight to Underweight on September 29, 2025, and dropped its price target from $53.20 to $42",
      "url": "https://finnhub.io/api/news?id=eb1acb147d75001c01456fb59f94888085eb7c4b0f7e7001cdfd8b5f9edb911d"
    },
    {
      "headline": "S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown",
      "source": "Yahoo",
      "datetime": 1759352755,
      "summary": "The S&P 500 and the Dow Jones Industrial Average hit new record highs on Wednesday as traders appear",
      "url": "https://finnhub.io/api/news?id=46463ae646d7ca61aa8571ec1d7bcf123f5787c7df74df4a1cce9896692a2f53"
    },
    {
      "headline": "Drug Stock Rally Helps Push Dow and S&P 500 to Records",
      "source": "Yahoo",
      "datetime": 1759352100,
      "summary": "Pharma stocks climbed for a second session, extending gains that began after President  Trump  unveiled a direct-to-consumer website for Americans to buy drugs.  Amgen  and  Merck  both climbed more than 5%, to push the Dow Jones Industrial Average up 0.1% to its second straight record.  Thermo Fish",
      "url": "https://finnhub.io/api/news?id=5bd585c49d43673b5051763e94a1a7fc8e306395cab56ea3da2dff38efde8a23"
    },
    {
      "headline": "Why Is Eli Lilly (LLY) Stock Rocketing Higher Today",
      "source": "Yahoo",
      "datetime": 1759348860,
      "summary": "Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 8.6% in the afternoon session after the stock's positive momentum continued as the White House revealed plans to launch a website for consumers to purchase drugs from manufacturers at a discount, providing clarity for the pharmaceut",
      "url": "https://finnhub.io/api/news?id=81347767ccf84273084dc94aff1d1234b7d2cd68af6035a8f8ca2ac423ab0505"
    },
    {
      "headline": "Why Merck (MRK) Stock Is Up Today",
      "source": "Yahoo",
      "datetime": 1759348850,
      "summary": "Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 7.7% in the afternoon session after the Trump administration announced a new program to sell drugs directly to consumers.",
      "url": "https://finnhub.io/api/news?id=486fce15972b9fed8e3956ff090de0e7fa1db96758b3a92330e210d6b93ed58a"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-10-01",
      "description": "xslF345X05/form4-10012025_041001.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000011/xslF345X05/form4-10012025_041001.xml"
    },
    {
      "form": "4",
      "date": "2025-09-22",
      "description": "xslF345X05/form4-09222025_040901.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000009/xslF345X05/form4-09222025_040901.xml"
    },
    {
      "form": "4",
      "date": "2025-09-19",
      "description": "xslF345X05/form4-09192025_040901.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000007/xslF345X05/form4-09192025_040901.xml"
    },
    {
      "form": "4",
      "date": "2025-09-17",
      "description": "xslF345X05/wk-form4_1758142191.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000126238825000004/xslF345X05/wk-form4_1758142191.xml"
    },
    {
      "form": "4",
      "date": "2025-09-17",
      "description": "xslF345X05/wk-form4_1758142140.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000242/xslF345X05/wk-form4_1758142140.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}